Corteria Pharmaceuticals, a Paris-based biopharmaceutical company, has raised €65 million in Series A funding to advance its pipeline of therapies for heart failure subpopulations....
Epigenic Therapeutics, a Shanghai-based biotechnology company dedicated to developing gene modulation therapy to treat prevalent diseases, has raised $32 million in Series A funding. The...